Cargando…

Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis

Light chain (AL) amyloidosis is a lethal form of systemic amyloidosis that arises from the clonal expansion of CD38+ plasma cells. Organ damage occurs when these plasma cells produce misfolded immunoglobulin light chains, which form amyloid fibrils and deposit in tissues. A minority of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapkota, Surendra, Kuehl, Sapna, Pulluri, Bhargavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830280/
https://www.ncbi.nlm.nih.gov/pubmed/36636680
http://dx.doi.org/10.1159/000527169
_version_ 1784867636335607808
author Sapkota, Surendra
Kuehl, Sapna
Pulluri, Bhargavi
author_facet Sapkota, Surendra
Kuehl, Sapna
Pulluri, Bhargavi
author_sort Sapkota, Surendra
collection PubMed
description Light chain (AL) amyloidosis is a lethal form of systemic amyloidosis that arises from the clonal expansion of CD38+ plasma cells. Organ damage occurs when these plasma cells produce misfolded immunoglobulin light chains, which form amyloid fibrils and deposit in tissues. A minority of patients with AL amyloidosis show “raccoon eyes” caused by increased vascular fragility from accumulation of amyloid fibrils. Amyloidosis can be directly associated with bleeding diathesis due to factor X deficiency as factor X binds to amyloid fibrils primarily in the liver and spleen. A 65-year-old Caucasian male presented with random bruising in the upper chest and around the eyes for 1.5 years. Physical examination was unremarkable, except for neck bruising. Pertinent workup showed protein electrophoresis with a faint M spike, increased serum lambda light chains, a kappa to lambda ratio of 0.06, increased Bence-Jones proteins, reduced factor X activity, elevated NT-proBNP. The bone marrow biopsy was positive for Congo red stain for amyloid protein. Magnetic resonance imaging revealed diffuse enhancement of the right and left ventricle subendocardial late gadolinium, consistent with cardiac amyloidosis. The patient started systemic therapy with a regimen of daratumumab, cyclophosphamide, bortezomib, and dexamethasone. After one cycle of therapy, lambda light chains normalized with an improvement in bruising. Diagnostic delays for cardiac patients are concerning as the median survival rate among these patients, when not treated, is approximately 6 months after the onset of symptoms. Since timely treatment can prevent organ damage, clinicians should be aware of specific clinical signs such as raccoon eyes and the importance of systemic evaluation for a prompt diagnosis.
format Online
Article
Text
id pubmed-9830280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-98302802023-01-11 Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis Sapkota, Surendra Kuehl, Sapna Pulluri, Bhargavi Case Rep Oncol Case Report Light chain (AL) amyloidosis is a lethal form of systemic amyloidosis that arises from the clonal expansion of CD38+ plasma cells. Organ damage occurs when these plasma cells produce misfolded immunoglobulin light chains, which form amyloid fibrils and deposit in tissues. A minority of patients with AL amyloidosis show “raccoon eyes” caused by increased vascular fragility from accumulation of amyloid fibrils. Amyloidosis can be directly associated with bleeding diathesis due to factor X deficiency as factor X binds to amyloid fibrils primarily in the liver and spleen. A 65-year-old Caucasian male presented with random bruising in the upper chest and around the eyes for 1.5 years. Physical examination was unremarkable, except for neck bruising. Pertinent workup showed protein electrophoresis with a faint M spike, increased serum lambda light chains, a kappa to lambda ratio of 0.06, increased Bence-Jones proteins, reduced factor X activity, elevated NT-proBNP. The bone marrow biopsy was positive for Congo red stain for amyloid protein. Magnetic resonance imaging revealed diffuse enhancement of the right and left ventricle subendocardial late gadolinium, consistent with cardiac amyloidosis. The patient started systemic therapy with a regimen of daratumumab, cyclophosphamide, bortezomib, and dexamethasone. After one cycle of therapy, lambda light chains normalized with an improvement in bruising. Diagnostic delays for cardiac patients are concerning as the median survival rate among these patients, when not treated, is approximately 6 months after the onset of symptoms. Since timely treatment can prevent organ damage, clinicians should be aware of specific clinical signs such as raccoon eyes and the importance of systemic evaluation for a prompt diagnosis. S. Karger AG 2022-11-11 /pmc/articles/PMC9830280/ /pubmed/36636680 http://dx.doi.org/10.1159/000527169 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Sapkota, Surendra
Kuehl, Sapna
Pulluri, Bhargavi
Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title_full Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title_fullStr Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title_full_unstemmed Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title_short Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
title_sort do not ignore those raccoon eyes; they may indicate lethal al amyloidosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830280/
https://www.ncbi.nlm.nih.gov/pubmed/36636680
http://dx.doi.org/10.1159/000527169
work_keys_str_mv AT sapkotasurendra donotignorethoseraccooneyestheymayindicatelethalalamyloidosis
AT kuehlsapna donotignorethoseraccooneyestheymayindicatelethalalamyloidosis
AT pulluribhargavi donotignorethoseraccooneyestheymayindicatelethalalamyloidosis